[Beta-2 microglobulin and amyloid osteoarthropathy in patients undergoing chronic hemodialysis].
The incidence of beta-2 microglobulin amyloidosis was assessed in two populations of chronic hemodialysis patients. Out of 34 patients who underwent biopsy during orthopedic surgery (33 cases) or autopsy (1 case), 26 had amyloid deposits which fixed anti-beta microglobulin serum. Out of 55 unselected patients treated for over months at the dialysis centre, 14 (25%) had clinical symptoms suggesting amyloidosis and out of 43 patients who had a systematic radiological skeletal survey, 23 (53%) had bone deposits. The plasma beta microglobulin concentrations (about 20 times the normal value) we not significantly different whether or not the patients had histological proven amyloidosis, clinically or radiologically probable amyloidosis, no detectable amyloidosis. However, the duration of hemodialysis was longer in those with proven or highly probable amyloidosis. The finding illustrate the indirect role of elevation of beta-2 microglobulin in the genesis of this pathology and also the necessity of lowering its concentration in order to avoid the long term complications of osteoarticular deposits, the functional consequences of which may be very serious.
Prinseau
J
J
Service de Médecine Interne, Néphrologie et Hémodialyse, Hôpital Ambroise Paré, Boulogne-Billancourt.
Baglin
A
A
Benoit
J
J
Leparc
J M
JM
Got
C
C
Louis
M F
MF
Attar
B
B
Fritel
D
D
D000328:Adult; D000368:Aged; D000686:Amyloidosis / Q000097:blood / Q000209:etiology* / Q000601:surgery; D001847:Bone Diseases / Q000097:blood / Q000209:etiology* / Q000601:surgery; D005260:Female; D006801:Humans; D007592:Joint Diseases / Q000097:blood / Q000209:etiology* / Q000601:surgery; D007676:Kidney Failure, Chronic / Q000628:therapy; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis / Q000009:adverse effects*; D001613:beta 2-Microglobulin / Q000032:analysis*
D001613:beta 2-Microglobulin
Bêta-2-microglobuline et ostéo-arthropathies amyloïdes de l'hémodialysé chronique.